接受血液透析的尿毒症患者血浆中的淋巴细胞毒素和混合白细胞培养阻断因子活性
Lymphocytotoxins and mixed leucocyte culture blocking factor activity in the plasma of uraemic patients undergoing haemodialysis.
作者信息
Sengar D P, Rashid A, Perelmutter L, Harris J E
出版信息
Clin Exp Immunol. 1975 May;20(2):249-55.
Abstract
Mixed leucocyte culture blocking factor activity (MLC-BFA) in the plasma of haemodialysis patients appears as a result of recent blood transfusions and is concentrated in IgG fractions of the blocking serum. Four patients neither developed lymphocytotoxins nor MLC-BFA in spite of having received multiple blood transfusions. Such 'unresponsive' recipients had an excellent clinical course upon receiving an allograft.
摘要
血液透析患者血浆中的混合白细胞培养阻断因子活性（MLC - BFA）是近期输血的结果，且集中在阻断血清的IgG组分中。尽管有4名患者接受了多次输血，但既未产生淋巴细胞毒素，也未出现MLC - BFA。这些“无反应性”受者在接受同种异体移植后临床过程良好。
相似文献
1
2
3
In vitro reactivity of lymphocytes obtained from uraemic patients maintained by heamodialysis.接受血液透析维持治疗的尿毒症患者淋巴细胞的体外反应性。
Clin Exp Immunol. 1975 Aug;21(2):298-305.
4
Relationship of blood transfusions to appearance of mixed leukocyte culture blocking factor activity in plasma of uraemic patients and renal allograft recipients.输血与尿毒症患者及肾移植受者血浆中混合白细胞培养阻断因子活性出现的关系。
Vox Sang. 1974;27(1):1-12. doi: 10.1111/j.1423-0410.1974.tb02383.x.
5
Mixed leucocyte culture blocking factor activity in the plasma of patients with cancer.癌症患者血浆中的混合白细胞培养阻断因子活性。
Oncology. 1974;30(5):393-404. doi: 10.1159/000224980.
6
Humoral and cell-mediated immunity in transfused uraemics.输血性尿毒症患者的体液免疫和细胞介导免疫
Proc Eur Dial Transplant Assoc. 1973;10(0):455-63.
7
The influence of blood transfusions on lymphocyte reactivity in man.输血对人体淋巴细胞反应性的影响。
Proc Eur Dial Transplant Assoc. 1983;19:453-9.
8
[MLC reactivity demonstrates transfusion-induced immunosuppression].[混合淋巴细胞培养反应性显示输血诱导的免疫抑制]
Beitr Infusionsther Transfusionsmed. 1994;32:293-6.
9
The humoral responses of haemodialysis patients to antigen challenge.血液透析患者对抗原刺激的体液反应。
Transplantation. 1976 Jul;22(1):18-23. doi: 10.1097/00007890-197607000-00003.
10
Mixed leucocyte culture, pre- transplant transfusions and renal allograft rejection.混合淋巴细胞培养、移植前输血与同种异体肾移植排斥反应
Proc Eur Dial Transplant Assoc. 1973;10(0):464-70.
引用本文的文献
本文引用的文献
1
Low molecular weight factors in normal human serum which block passive sensitization by reagins.正常人血清中可阻断反应素介导的被动致敏作用的低分子量因子。
Int Arch Allergy Appl Immunol. 1969;35(4):369-80. doi: 10.1159/000230189.
2
Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test.同种移植的血清分型。18. 微滴淋巴细胞细胞毒性试验的改进。
Transplantation. 1968 Nov;6(8):913-27. doi: 10.1097/00007890-196811000-00006.
3
A semimicro mixed leukocyte culture test.半微量混合白细胞培养试验。
Transplantation. 1971 Mar;11(3):260-7. doi: 10.1097/00007890-197103000-00004.
4
5
Cellular and humoral factors governing canine mixed lymphocyte cultures after renal transplantation. I. Antibody.肾移植后调控犬混合淋巴细胞培养的细胞和体液因子。I. 抗体。
Transplantation. 1971 Jul;12(1):65-76. doi: 10.1097/00007890-197107000-00012.
6
HL-A unresponsiveness induced by weekly transfusions of small aliquots of whole blood.每周输注少量全血诱导的HL-A无反应性。
Transplantation. 1974 Feb;17(2):194-200. doi: 10.1097/00007890-197402000-00007.
7
Blood transfusions and unresponsiveness to HL-A.输血与对组织相容性白细胞抗原（HL-A）无反应性
Transplantation. 1973 Dec;16(6):649-54. doi: 10.1097/00007890-197312000-00017.
8
Effect of blood transfusions on subsequent kidney transplants.输血对后续肾脏移植的影响。
Transplant Proc. 1973 Mar;5(1):253-9.
9
Suppression of mixed leukocyte response by plasma from hemodialysis patients.血液透析患者血浆对混合淋巴细胞反应的抑制作用。
Tissue Antigens. 1973;3(1):22-9. doi: 10.1111/j.1399-0039.1973.tb00974.x.
10
Specificity of antibodies that inhibit the MLC response.抑制MLC反应的抗体的特异性。
Transplant Proc. 1973 Dec;5(4):1859-62.
Zotero 插件